trending Market Intelligence /marketintelligence/en/news-insights/trending/JNVqTHXTQn3j5pWqC4AagQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Vanc Pharmaceuticals appoints board member

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Vanc Pharmaceuticals appoints board member

Vanc Pharmaceuticals Inc. appointed Robert Sindelar to its board of directors.

The Vancouver, British Columbia-based generic and over-the-counter medicine manufacturer said Sindelar serves as professor, faculty of pharmaceutical sciences at the University of British Columbia.

"Sindelar's background is ideally suited to helping VANC build upon the increasing importance of community pharmacy in healthcare," CEO Bob Rai said in a statement.

Sindelar added: "Current trends suggest that community pharmacy's direct role in patient care services and wellness are growing and VANC has focused on delivering proven enabling technologies to further support this trend and the attendant growth in community pharmacy business activities."